These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Central nervous system involvement in progressive muscular dystrophy. Yoshioka M; Okuno T; Honda Y; Nakano Y Arch Dis Child; 1980 Aug; 55(8):589-94. PubMed ID: 7436514 [TBL] [Abstract][Full Text] [Related]
44. Scoliosis in muscular dystrophy. Some comments about diagnosis, observations on prognosis, and suggestions for therapy. Siegel IM Clin Orthop Relat Res; 1973 Jun; (93):235-8. PubMed ID: 4722946 [No Abstract] [Full Text] [Related]
45. Muscular dystrophy in childhood. Moosa A Dev Med Child Neurol; 1974 Feb; 16(1):97-111. PubMed ID: 4360435 [No Abstract] [Full Text] [Related]
46. [For the anatomo-clinical diagnosis of primary muscular dystrophy of neonatal onset: apropos of a case]. Bruni G; Zalla PG Arch De Vecchi Anat Patol; 1968 Mar; 51(1):435-45. PubMed ID: 5737308 [No Abstract] [Full Text] [Related]
47. Pseudohypertrophic muscular dystrophy and its surgical management: review of 30 patients. Roy L; Gibson DA Can J Surg; 1970 Jan; 13(1):13-21. PubMed ID: 4244311 [No Abstract] [Full Text] [Related]
48. Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence. Canavese F; Sussman MD J Pediatr Orthop; 2009 Mar; 29(2):208-13. PubMed ID: 19352249 [TBL] [Abstract][Full Text] [Related]
49. [Marked hyperinsulinemia in a patient with myotonic dystrophy]. Miyazaki K; Watanabe M; Ueno T; Mochizuki A; Shoji S Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):337-9. PubMed ID: 15768597 [No Abstract] [Full Text] [Related]
50. [Prognosis of progressive muscular dystrophy in children. Analysis of early and exact criteria]. Rideau Y Union Med Can; 1977 Jun; 106(6):874-82. PubMed ID: 883053 [No Abstract] [Full Text] [Related]
51. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease? Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936 [TBL] [Abstract][Full Text] [Related]
52. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G; Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240 [TBL] [Abstract][Full Text] [Related]
53. The cerebral defect and myopathy in Duchenne muscular dystrophy. A comparative clinicopathological study. Rosman NP Neurology; 1970 Apr; 20(4):329-35. PubMed ID: 5534965 [No Abstract] [Full Text] [Related]
54. [Genetic counseling in myotonia and muscular dystrophy]. Becker PE Internist (Berl); 1978 Aug; 19(8):475-81. PubMed ID: 357337 [No Abstract] [Full Text] [Related]
55. Assessment of left ventricular systolic and diastolic functions in children with merosin-positive congenital muscular dystrophy. Ceviz N; Alehan F; Alehan D; Ozme S; Akçören Z; Kale G; Topaloglu H Int J Cardiol; 2003 Feb; 87(2-3):129-33; discussion 133-4. PubMed ID: 12559529 [TBL] [Abstract][Full Text] [Related]
56. The muscular dystrophies. Clinical update on two major types. Appel SH Postgrad Med; 1978 Aug; 64(2):93-102. PubMed ID: 673985 [TBL] [Abstract][Full Text] [Related]
57. Fukuyama congenital muscular dystrophy in two Australian female siblings. Stern LM; Albertyn L; Manson JI Dev Med Child Neurol; 1990 Sep; 32(9):808-13. PubMed ID: 2227144 [TBL] [Abstract][Full Text] [Related]